Symbol:
Slc35g2
Name:
solute carrier family 35, member G2
Description:
ASSOCIATED WITH melanoma (ortholog); FOUND IN Golgi apparatus (ortholog); plasma membrane (ortholog); INTERACTS WITH benzo[a]pyrene; benzo[b]fluoranthene; chrysene
Type:
protein-coding
RefSeq Status:
VALIDATED
Also known as:
Gm519; solute carrier family 35 member G2; Tmem22; transmembrane protein 22
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC35G2 (solute carrier family 35 member G2) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Slc35g2 (solute carrier family 35, member G2) HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, PhylomeDB, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Slc35g2 (solute carrier family 35 member G2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC35G2 (solute carrier family 35 member G2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC35G2 (solute carrier family 35 member G2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC35G2 (solute carrier family 35 member G2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Slc35g2 (solute carrier family 35, member G2)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Homo sapiens (human):
SLC35G2 (solute carrier family 35 member G2)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Danio rerio (zebrafish):
slc35g2a (solute carrier family 35 member G2a)
Alliance
DIOPT (Hieranoid, InParanoid, OrthoFinder, OrthoInspector, PANTHER, TreeFam, ZFIN)
Danio rerio (zebrafish):
slc35g2b (solute carrier family 35 member G2b)
Alliance
DIOPT (Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, ZFIN)
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm38 9 100,549,125 - 100,571,085 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 MGSCv37 9 100,452,607 - 100,471,504 (-) NCBI GRCm37 mm9 NCBIm37 MGSCv36 9 100,361,540 - 100,390,593 (-) NCBI mm8 Celera 9 100,090,867 - 100,109,646 (-) NCBI Celera Cytogenetic Map 9 E3.3 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
(RS)-amphetamine increases expression ISO RGD:1306109 6480464 Amphetamine results in increased expression of SLC35G2 mRNA CTD PMID:30779732 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE affects response to substance ISO RGD:1314532 6480464 SLC35G2 protein affects the susceptibility to Topotecan CTD PMID:16217747 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314532 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC35G2 mRNA CTD PMID:26238291 2-methylcholine affects expression ISO RGD:1314532 6480464 beta-methylcholine affects the expression of SLC35G2 mRNA CTD PMID:21179406 aflatoxin B1 increases expression ISO RGD:1314532 6480464 Aflatoxin B1 results in increased expression of SLC35G2 mRNA CTD PMID:21641981 , PMID:27153756 benzo[a]pyrene increases expression ISO RGD:1314532 6480464 Benzo(a)pyrene results in increased expression of SLC35G2 mRNA CTD PMID:20064835 more ... benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314532 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA CTD PMID:27858113 bisphenol A decreases expression ISO RGD:1306109 6480464 bisphenol A results in decreased expression of SLC35G2 mRNA CTD PMID:25181051 carbamazepine affects expression ISO RGD:1314532 6480464 Carbamazepine affects the expression of SLC35G2 mRNA CTD PMID:25979313 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA CTD PMID:27858113 copper atom multiple interactions ISO RGD:1314532 6480464 [NSC 689534 binds to Copper] which results in increased expression of SLC35G2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1314532 6480464 [NSC 689534 binds to Copper] which results in increased expression of SLC35G2 mRNA CTD PMID:20971185 copper(2+) multiple interactions ISO RGD:1314532 6480464 [NSC 689534 binds to Copper] which results in increased expression of SLC35G2 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO RGD:1314532 6480464 Copper Sulfate results in increased expression of SLC35G2 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1314532 6480464 Cyclosporine results in increased expression of SLC35G2 mRNA CTD PMID:20106945 , PMID:25562108 cylindrospermopsin increases expression ISO RGD:1314532 6480464 cylindrospermopsin results in increased expression of SLC35G2 mRNA CTD PMID:24921660 diuron decreases expression ISO RGD:1306109 6480464 Diuron results in decreased expression of SLC35G2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1314532 6480464 entinostat results in increased expression of SLC35G2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 hydrogen peroxide affects expression ISO RGD:1314532 6480464 Hydrogen Peroxide affects the expression of SLC35G2 mRNA CTD PMID:20044591 lead(0) affects expression ISO RGD:1314532 6480464 Lead affects the expression of SLC35G2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1314532 6480464 Lead affects the expression of SLC35G2 mRNA CTD PMID:28903495 leflunomide increases expression ISO RGD:1314532 6480464 leflunomide results in increased expression of SLC35G2 mRNA CTD PMID:28988120 mercury dibromide increases expression ISO RGD:1314532 6480464 mercuric bromide results in increased expression of SLC35G2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1314532 6480464 methylmercuric chloride results in increased expression of SLC35G2 mRNA CTD PMID:28001369 p-chloromercuribenzoic acid increases expression ISO RGD:1314532 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC35G2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 phenylmercury acetate increases expression ISO RGD:1314532 6480464 Phenylmercuric Acetate results in increased expression of SLC35G2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 quercetin increases expression ISO RGD:1314532 6480464 Quercetin results in increased expression of SLC35G2 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1314532 6480464 Silicon Dioxide analog results in increased expression of SLC35G2 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1314532 6480464 sodium arsenite results in increased expression of SLC35G2 mRNA CTD PMID:21281968 Soman decreases expression ISO RGD:1306109 6480464 Soman results in decreased expression of SLC35G2 mRNA CTD PMID:19281266 tert-butyl hydroperoxide increases expression ISO RGD:1314532 6480464 tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA CTD PMID:15336504 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA CTD PMID:27858113 thapsigargin increases expression ISO RGD:1314532 6480464 Thapsigargin results in increased expression of SLC35G2 mRNA CTD PMID:29453283 topotecan affects response to substance ISO RGD:1314532 6480464 SLC35G2 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A increases expression ISO RGD:1314532 6480464 trichostatin A results in increased expression of SLC35G2 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:1314532 6480464 Valproic Acid affects the expression of SLC35G2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1314532 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314532 6480464 Valproic Acid results in increased expression of SLC35G2 mRNA CTD PMID:23179753 more ... zalcitabine multiple interactions ISO RGD:1306109 6480464 [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SLC35G2 mRNA CTD PMID:18606552 
Gene-Chemical Interaction Annotations
